Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.

Neonatal diabetes is a rare monogenic form of diabetes that usually presents within the first six months of life. It is commonly caused by gain-of-function mutations in the genes encoding the Kir6.2 and SUR1 subunits of the plasmalemmal ATP-sensitive K+ (KATP) channel. To better understand this disease, we generated a mouse expressing a Kir6.2 mutation (V59M) that causes neonatal diabetes in humans and we used Cre-lox technology to express the mutation specifically in pancreatic beta cells. These beta-V59M mice developed severe diabetes soon after birth, and by 5 weeks of age, blood glucose levels were markedly increased and insulin was undetectable. Islets isolated from beta-V59M mice secreted substantially less insulin and showed a smaller increase in intracellular calcium in response to glucose. This was due to a reduced sensitivity of KATP channels in pancreatic beta cells to inhibition by ATP or glucose. In contrast, the sulfonylurea tolbutamide, a specific blocker of KATP channels, closed KATP channels, elevated intracellular calcium levels, and stimulated insulin release in beta-V59M beta cells, indicating that events downstream of KATP channel closure remained intact. Expression of the V59M Kir6.2 mutation in pancreatic beta cells alone is thus sufficient to recapitulate the neonatal diabetes observed in humans. beta-V59M islets also displayed a reduced percentage of beta cells, abnormal morphology, lower insulin content, and decreased expression of Kir6.2, SUR1, and insulin mRNA. All these changes are expected to contribute to the diabetes of beta-V59M mice. Their cause requires further investigation.

Pubmed ID: 19065048


  • Girard CA
  • Wunderlich FT
  • Shimomura K
  • Collins S
  • Kaizik S
  • Proks P
  • Abdulkader F
  • Clark A
  • Ball V
  • Zubcevic L
  • Bentley L
  • Clark R
  • Church C
  • Hugill A
  • Galvanovskis J
  • Cox R
  • Rorsman P
  • BrĂ¼ning JC
  • Ashcroft FM


The Journal of clinical investigation

Publication Data

January 7, 2009

Associated Grants

  • Agency: Wellcome Trust, Id: 084655
  • Agency: Medical Research Council, Id: MC_U142661184
  • Agency: Medical Research Council, Id:
  • Agency: Wellcome Trust, Id:

Mesh Terms

  • Adenosine Triphosphate
  • Animals
  • Calcium
  • Diabetes Mellitus
  • Disease Models, Animal
  • Female
  • Humans
  • Hypoglycemic Agents
  • Infant, Newborn
  • Insulin-Secreting Cells
  • Male
  • Mice
  • Mice, Transgenic
  • Mutation
  • Patch-Clamp Techniques
  • Potassium Channels, Inwardly Rectifying
  • Protein Subunits
  • Tolbutamide